Currently, the GDF-15 is not employed in any of the available molecular assays and we believe that its inclusion in the ThyroSeq v3 as well as Afirma GEC and other upcoming molecular assays could improve their efficacy as preoperative molecular diagnostic tools, which is crucial for the surgical management of the thyroid nodules. This evidence concerns the gene GDF15 and thyroid nodule.